drugset

drugset / Trial / NCT01600001

A Exploratory Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC)

NCT01600001 ↗

Phase 2 Completed 75 enrolled Kissei Pharmaceutical Co., Ltd.

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of KWA-0711 in Chronic Idiopathic Constipation (CIC) patients.

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	KWA-0711	Unknown	—	—

Indications